Drug, Nucleotide, and Lipid Interactions with P-glycoprotein
Drug, Nucleotide, and Lipid Interactions with P-glycoprotein
批准号:
10672242
负责人:
WILLIAM M ATKINS
金额:
$31.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-01 至 2026-04-30
关键词:
ABCB1 geneATP HydrolysisATP phosphohydrolaseATP-Binding Cassette TransportersBehaviorBindingBinding SitesCell membraneCellsChargeCholesterolCoupledCouplingDeuteriumDiseaseDrug InteractionsDrug resistanceElementsEnvironmentEquilibriumExhibitsExpenditureFluorescenceFluorescence SpectroscopyFood-Drug InteractionsGoalsHealthHeterogeneityHumanHydrogenKineticsKnowledgeLigand BindingLigandsLipid BilayersLipidsLiteratureMalignant NeoplasmsMass Spectrum AnalysisMeasuresMembraneMembrane FluidityMembrane LipidsMethodsMicellesMolecularMolecular BiologyMolecular ConformationNucleotidesNutrientPharmaceutical PreparationsPlayProteinsPumpReactionRoleSeriesSphingomyelinsStructureSuggestionSurfaceTheoretical modelTissuesTryptophanVesicleXenobioticscancer celldetoxicationefflux pumpflexibilityimprovedinhibitorkinetic modelnanodiskoverexpressionpreferencerecruitresidenceresponsesingle moleculesmall moleculestopped-flow fluorescence
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
P-glycoprotein pumps drugs, xenobiotics and nutrients out of cells via a partially characterized
ATP-dependent mechanism. Due to the extreme substrate promiscuity of P-gp, it contributes to
the disposition of nearly all small molecule drugs and to drug-drug interactions. P-gp may be
particularly important in cancer cell drug resistance due to its over expression in several
cancers. The aims of this proposal are to fill knowledge gaps in three distinct aspects of P-gp
mechanism. Each aim shares the common mechanistic element of conformational dynamics.
The first aim is to define the P-gp conformations at low ATP occupancy in order to understand
how they control downstream conformational changes that are essential for substrate efflux, and
how they are different in the presence vs. the absence of substrates. These conformational
differences are hypothesized to be essential for minimizing wasteful expenditure of ATP in the
absence of transportable substrate and to control proper conformational access in downstream
steps. These differences will be identified by rapid, pre-equilibrium, kinetic methods with state-
of-the-art kinetic modeling and Hydrogen/Deuterium Exchange Mass Spectrometry (H/DX) with
P-gp in lipid nanodiscs.
The second aim is to understand the extreme sensitivity of P-gp to its lipid environment. The
lipid nanodisc platform provides fine control of the lipid bilayer in which P-gp resides. P-gp will
be incorporated in nanodiscs with varying ratios of lipids with different head groups or acyl
chains that provide different surface charge of bilayer fluidity. The basal- and substrate
dependent ATPase activity in the different lipid environments will be correlated with changes in
conformation determined by H/DX.
The third aim is to determine the mechanism by which P-gp is able to interact with such a wide
range of substrates and inhibitors. Substrate promiscuity is an increasingly appreciated behavior
for many proteins throughout biology but the molecular basis is poorly defined. Here, pre
equilibrium binding kinetics and single molecule fluorescence methods will be used to compare
the distribution of binding parameters in P- gp ensembles vs. single P-gp nanodiscs in order to
determine whether P-gp exploits interconverting conformations or persistent distinct
conformations to recruit and retain drugs of varying structure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional Dynamics of Cytochrome P4503A4
-
批准号:9638812
-
项目类别:
-
资助金额:$49.63万
-
财政年份:2018
-
负责人:WILLIAM M ATKINS
-
依托单位:
Functional Dynamics of Cytochrome P4503A4
-
批准号:10205098
-
项目类别:
-
资助金额:$41.47万
-
财政年份:2018
-
负责人:WILLIAM M ATKINS
-
依托单位:
P450-Base Drug Interactions with Low Spin Drugs
-
批准号:8716902
-
项目类别:
-
资助金额:$45.19万
-
财政年份:2013
-
负责人:WILLIAM M ATKINS
-
依托单位:
P450-Base Drug Interactions with Low Spin Drugs
-
批准号:9120388
-
项目类别:
-
资助金额:$42.47万
-
财政年份:2013
-
负责人:WILLIAM M ATKINS
-
依托单位:
P450-Base Drug Interactions with Low Spin Drugs
-
批准号:8740514
-
项目类别:
-
资助金额:$42.47万
-
财政年份:2013
-
负责人:WILLIAM M ATKINS
-
依托单位:
Molecular Mechanisms of P-Glycoprotein
-
批准号:8162138
-
项目类别:
-
资助金额:$29.51万
-
财政年份:2011
-
负责人:WILLIAM M ATKINS
-
依托单位:
Molecular Mechanisms of P-Glycoprotein
-
批准号:8336839
-
项目类别:
-
资助金额:$28.11万
-
财政年份:2011
-
负责人:WILLIAM M ATKINS
-
依托单位:
Molecular Mechanisms of P-Glycoprotein
-
批准号:8531994
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2011
-
负责人:WILLIAM M ATKINS
-
依托单位:
P450 Allosterism and Drug Interactions
-
批准号:7559323
-
项目类别:
-
资助金额:$23.71万
-
财政年份:2008
-
负责人:WILLIAM M ATKINS
-
依托单位:
MECHANISMS OF CYTOCHROME P450 ALLOSTERY
-
批准号:6701456
-
项目类别:
-
资助金额:$21.62万
-
财政年份:2003
-
负责人:WILLIAM M ATKINS
-
依托单位:
Conformational Dynamics in Glutathione S-Transferase
-
批准号:6621762
-
项目类别:
-
资助金额:$22.92万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
Conformational Dynamics in Glutathione S-Transferase
-
批准号:6436574
-
项目类别:
-
资助金额:$23.8万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
Conformational Dynamics in Glutathione S-Transferase
-
批准号:6840399
-
项目类别:
-
资助金额:$22.9万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
Glutamine Synthetase Inhibitors for Tuberculosis Therapy
-
批准号:6762446
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
Glutamine Synthetase Inhibitors for Tuberculosis Therapy
-
批准号:6606878
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
Glutathione S-Transferases and Oxidative Stress
-
批准号:8006392
-
项目类别:
-
资助金额:$27.25万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
Conformational Dynamics in Glutathione S-Transferase
-
批准号:6687264
-
项目类别:
-
资助金额:$22.91万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
Glutamine Synthetase Inhibitors for Tuberculosis Therapy
-
批准号:6450223
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
Glutathione S-Transferases and Oxidative Stress
-
批准号:7556363
-
项目类别:
-
资助金额:$27.71万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
TIME RESOLVED TRYPTOPHAN FLUORESCENCE FROM CYTOCHROME B5
-
批准号:6444733
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2001
-
负责人:WILLIAM M ATKINS
-
依托单位:
海外基金